Swedish Orphan Biovitrum AG
- Sector unverified
- Rank 203 / 334
Swedish Orphan Biovitrum AG is recorded by Swissmedic as the authorisation holder for 5 human medicines, which places it 203 of 334 authorisation holders. Its portfolio is mostly in the Biotechnologika category (60 % of its authorisations). We hold no research of our own on this company's sector or business model, so we assign it to none.
Sector unverified: the Swissmedic list carries no sector field and we have not researched this company.
Key facts
| Sector | Not available |
|---|---|
| City | Not available |
| Canton | Not available |
| Authorisation holder | Yes |
| Medicines | 5 |
| Founded | Not available |
| Employees | Not available |
| Parent group | Not available |
| Activity | Not available |
| Website | Not available |
Medicines authorised in Switzerland
Swedish Orphan Biovitrum AG is recorded by Swissmedic as the authorisation holder for 5 human medicines. The table shows 5 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
5 of 5 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| Alprolix 250 IE | 66039 | B | B02BD04 | 2016-10-25 |
| Altuvoct 250 I.E. | 69436 | B | B02BD02 | 2024-09-02 |
| Aspaveli | 68674 | A | L04AJ03 | 2023-03-23 |
| Doptelet 20 mg | 67893 | A | B02BX08 | 2021-11-23 |
| Elocta 250 I.E. | 65843 | B | B02BD02 | 2016-06-23 |
Frequently asked questions
How many medicines does Swedish Orphan Biovitrum AG have authorised in Switzerland?
Swedish Orphan Biovitrum AG is recorded by Swissmedic as the authorisation holder for 5 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is Swedish Orphan Biovitrum AG based?
We have no confirmed Swiss address for Swedish Orphan Biovitrum AG. We add it as soon as the commercial register or the company confirms it.
Is Swedish Orphan Biovitrum AG a Swissmedic authorisation holder?
Yes. Swedish Orphan Biovitrum AG appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.